Literature DB >> 25336562

Colorectal cancer screening in first nations people living in Manitoba.

Kathleen M Decker1, Alain A Demers2, Erich V Kliewer3, Grace Musto4, Emma Shu4, Natalie Biswanger5, Brenda Elias6, Jane Griffith2, Donna Turner7.   

Abstract

BACKGROUND: Because the burden of colorectal cancer (CRC) seems to be increasing in First Nations, it is important to better understand CRC screening utilization. The objective of this study was to describe CRC screening among First Nations living in Manitoba.
METHODS: The Federal Indian Register was linked to two provincial databases. A negative binomial model was used to compare the probability of First Nations having a fecal occult blood test (FOBT), colonoscopy, or flexible sigmoidoscopy (FS) with all other Manitobans.
RESULTS: First Nations who lived in Winnipeg were significantly less likely to have had a FOBT in the previous 2 years than all other Manitobans who lived in Winnipeg [rate ratio (RR) = 0.40; 95% confidence intervals (CI), 0.37-0.44]. There was no difference in the likelihood of having a colonoscopy or FS for First Nations individuals who resided in northern Manitoba compared with all other Manitobans (RR, 1.04; 95% CI, 0.91-1.19). However, First Nations who lived in the rural south or urban areas were less likely than all other Manitobans to have had a colonoscopy or FS (RR, 0.81, 95% CI, 0.75-0.87, rural south; RR, 0.86, 95% CI, 0.81-0.92, urban).
CONCLUSIONS: First Nations living in Winnipeg were significantly less likely to be screened for CRC using the FOBT. Colonoscopy and FS use depended on area of residence. IMPACT: First Nations experience barriers that impede the use of CRC screening. Further research is needed to understand these barriers to extend the benefit of CRC screening to this population. Cancer Epidemiol Biomarkers Prev; 24(1); 241-8. ©2014 AACR. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2014        PMID: 25336562     DOI: 10.1158/1055-9965.EPI-14-1008

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  4 in total

1.  Cancer incidence, mortality, and stage at diagnosis in First Nations living in Manitoba.

Authors:  K M Decker; E V Kliewer; A A Demers; K Fradette; N Biswanger; G Musto; B Elias; D Turner
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

2.  Cancer incidence, stage at diagnosis and outcomes among Manitoba First Nations people living on and off reserve: a retrospective population-based analysis.

Authors:  Tara C Horrill; Lindsey Dahl; Esther Sanderson; Garry Munro; Cindy Garson; Randy Fransoo; Genevieve Thompson; Catherine Cook; Janice Linton; Annette S H Schultz
Journal:  CMAJ Open       Date:  2019-12-18

3.  Geographic variation and factors associated with colorectal cancer incidence in Manitoba.

Authors:  Harminder Singh; Zoann Nugent; Kathleen Decker; Alain Deniers; Jewel Samaddar; Mahmoud Torabi
Journal:  Can J Public Health       Date:  2017-09-01

4.  Evaluating the impact of the COVID-19 pandemic on cancer screening in a central Canadian province.

Authors:  Kathleen M Decker; Allison Feely; Oliver Bucher; Harminder Singh; Donna Turner; Pascal Lambert
Journal:  Prev Med       Date:  2022-01-19       Impact factor: 4.018

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.